Kevin Feeley - Jun 1, 2023 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Role
Chief Financial Officer
Signature
/s/ Devin Schaffer, Attorney-in-Fact
Stock symbol
WGS
Transactions as of
Jun 1, 2023
Transactions value $
-$1,841
Form type
4
Date filed
6/5/2023, 04:42 PM
Previous filing
May 18, 2023
Next filing
Jun 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WGS Class A Common Stock Options Exercise +718 +18.62% 4.58K Jun 1, 2023 Direct F1
transaction WGS Class A Common Stock Sale -$1.84K -263 -5.75% $7.00 4.31K Jun 2, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WGS Restricted Stock Unit Options Exercise $0 -718 -7.15% $0.00 9.33K Jun 1, 2023 Class A Common Stock 718 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
F2 The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F3 25% of the total RSUs vested on April 29, 2023 and April 29, 2024, and thereafter 6.25% of the total shares underlying the award shall vest in equal quarterly installments until fully vested on April 29, 2026, subject to the Reporting Person's continued service to the Issuer on each vesting date.